They're used to forecast the longitudinal behavior of trial participants – and by predicting individuals' likely response to a drug, can improve data quality and shorten trial timelines, says Unlearn CEO Steven Herne. Global Precision Medicine By HIMSS TV | April 30, 2025 | 11:11 AM Topic: Analytics, Artificial Intelligence, Population Health, Precision Medicine
